EUVIMEDEUVIMED entdecken
Crossref

Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1

Kaiyuan Liu, Liuye Yang, Pengchao Wang, Jingbo Zhu, Fengcen Li, Jiangtong Peng, Kai Huang, Minglu Liang

Inflammopharmacology · 2024

DOI: 10.1007/s10787-024-01448-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammopharmacology, 2024. Verfasst von Kaiyuan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan,…. Hauptthemen laut MEDLINE: Inflammation, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Knockout. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis, a life-threatening condition characterized by dysregulated immune responses, remains a significant clinical challenge. Myricanol, a natural compound, plays a variety of roles in regulating lipid metabolism, anti-cancer, anti-neurodegeneration, and it could act as an Sirtuin 1 (SIRT1) activator. This study aimed to explore the therapeutic potential and underlying mechanism of myricanol in the lipopolysaccharide (LPS)-induced sepsis model. In vivo studies revealed that myricanol administration significantly improved the survival rate of LPS-treated mice, effectively mitigating LPS-induced inflammatory responses in lung tissue. Furthermore, in vitro studies demonstrated that myricanol treatment inhibited the expression of pro-inflammatory cytokines, attenuated signal pathway activation, and reduced oxidative stress in macrophages. In addition, we demonstrated that myricanol selectively enhances SIRT1 activation in LPS-stimulated macrophages, and all of the protective effect of myricanol were reversed through SIRT1 silencing. Remarkably, the beneficial effects of myricanol against LPS-induced sepsis were abolished in SIRT1 myeloid-specific knockout mice, underpinning the critical role of SIRT1 in mediating myricanol's therapeutic efficacy. In summary, this study provides significant evidence that myricanol acts as a potent SIRT1 activator, targeting inflammatory signal pathways and oxidative stress to suppress excessive inflammatory responses. Our findings highlight the potential of myricanol as a novel therapeutic agent for the treatment of LPS-induced sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationLipopolysaccharidesMice, Inbred C57BLMice, KnockoutNF-E2-Related Factor 2NF-kappa BSepsisSignal TransductionSirtuin 1Up-RegulationAnimalsMaleMiceAnti-Inflammatory AgentsMacrophagesMitogen-Activated Protein KinasesOxidative StressRAW 264.7 Cells

Stichwörter der Autor:innen

InflammationMyricanolOxidative stressSIRT1Sepsis

Substanzen

Anti-Inflammatory AgentsLipopolysaccharidesMitogen-Activated Protein KinasesNF-E2-Related Factor 2NF-kappa BNfe2l2 protein, mouseSirt1 protein, mouseSirtuin 1

Autor:innen und Institutionen

  • Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, 430022, China.
  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, 430022, China. pjthust@126.com.
  • Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Wuhan, China. pjthust@126.com.
  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. pjthust@126.com.
  • Hubei Clinical Research Center for Metabolic and Cardiovascular Disease, Wuhan, China. pjthust@126.com.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Liu, K., Yang, L., Wang, P., Zhu, J., Li, F., Peng, J., Huang, K., & Liang, M. (2024). Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1. Inflammopharmacology. https://doi.org/10.1007/s10787-024-01448-5

Vancouver

Liu K, Yang L, Wang P, Zhu J, Li F, Peng J, et al. Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1. Inflammopharmacology. 2024. doi:10.1007/s10787-024-01448-5

BibTeX
@article{Liu2024,
  author = {Liu, Kaiyuan and Yang, Liuye and Wang, Pengchao and Zhu, Jingbo and Li, Fengcen and Peng, Jiangtong and Huang, Kai and Liang, Minglu},
  title = {Myricanol attenuates sepsis-induced inflammatory responses by nuclear factor erythroid 2-related factor 2 signaling and nuclear factor kappa B/mitogen-activated protein kinase pathway via upregulating Sirtuin 1},
  journal = {Inflammopharmacology},
  year = {2024},
  doi = {10.1007/s10787-024-01448-5}
}
Kostenlos starten →